Autobahn Therapeutics Announces Successful Financing to Support Strategic Advancement of ABX-002 for Treatment Resistant Depression Read more
FDA Approves Sotyktu (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis Read more
Gatehouse Bio Extends Its Partnership with AstraZeneca to Develop RNA Therapeutics for Heart Failure Read more
Anthos Therapeutics Announces that Abelacimab Has Received FDA Fast Track Designation for the Prevention of Stroke and Systemic Embolism in Patients with Atrial Fibrillation Read more
FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women Read more
Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 Program by Roche Read more
Tetra Collaborates with Cellvera to Develop a Potential Oral Combination Treatment for COVID-19 Patients Read more
AceLink Therapeutics Receives Orphan Drug Designation for its Novel GCS Inhibitor AL01211 for the Treatment of Fabry Disease Read more